# Rosuvastatin in Preventing Myonecrosis in Elective Percutaneous Coronary Interventions (PCIs)

> **NCT01007279** · PHASE3 · COMPLETED · sponsor: **University of Roma La Sapienza** · enrollment: 160 (estimated)

## Conditions studied

- Periprocedural Myocardial Necrosis

## Interventions

- **DRUG:** ROSUVASTATIN

## Key facts

- **NCT ID:** NCT01007279
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2010-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01007279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01007279, "Rosuvastatin in Preventing Myonecrosis in Elective Percutaneous Coronary Interventions (PCIs)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01007279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*